Ruxolitinib in Children with Steroid Refractory Acute Graft Versus Host Disease: A Multicenter Study of the Pediatric Group of SFGM-TC - Archive ouverte HAL Access content directly
Journal Articles Pediatric Blood and Cancer Year : 2019
Not file

Dates and versions

hal-02355531 , version 1 (08-11-2019)

Identifiers

  • HAL Id : hal-02355531 , version 1

Cite

L. Laisne, B. Neven, J. H. Dalle, C. Galambrun, M. Esvan, et al.. Ruxolitinib in Children with Steroid Refractory Acute Graft Versus Host Disease: A Multicenter Study of the Pediatric Group of SFGM-TC. Pediatric Blood and Cancer, 2019, 66, pp.S43-S44. ⟨hal-02355531⟩
25 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More